Treatment with 3-NBA clearly increased the frequency of TP53 mutations over that of untreated cultures, but, interestingly, Xpa-deficiency did not further increase the mutation frequency induced by 3-NBA. This evidence concerns the gene XPA and hyperinsulinemic hypoglycemia, familial, 4.